Brief: Nyxoah Says Co Receives Approval From FDA For Genio® System For Treatment Of Obstructive Sleep Apnea
Aug 8 (Reuters) - Nyxoah SA NYXH.BR: EQS-NEWS: NYXOAH RECEIVES APPROVAL FROM FDA FOR GENIO® SYSTEM FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA NYXOAH SA - LAUNCHES U.S. COMMERCIALIZATION Source text: ID:nEQ1V7jbka Further company coverage: NYXH.BR ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer